​
​

DiaMedica Therapeutics (DMAC) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

DiaMedica Therapeutics Revenue Highlights

00

DiaMedica Therapeutics Revenue by Period

DiaMedica Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--100.00%
2018-12-31$500.00K100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31--100.00%
2007-12-31$160.62K524.07%
2006-12-31$25.74K0.23%
2005-12-31$25.68K-24.21%
2004-12-31$33.88K-

DiaMedica Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

DiaMedica Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$30.84M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31--100.00%
2022-09-30$76.00K484.62%
2022-06-30$13.00K100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--100.00%
2018-12-31$-3.66K-100.73%
2018-09-30$503.66K100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31--100.00%
2008-12-31$-73.28K-479.55%
2008-09-30$19.31K-20.20%
2008-06-30$24.19K-23.40%
2008-03-31$31.58K-15.92%
2007-12-31$37.56K-

DiaMedica Therapeutics generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

DiaMedica Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MCRBSeres Therapeutics$126.33M-
HOOKHOOKIPA Pharma$20.13M-
SCPHscPharmaceuticals$13.59M$8.05M
CNTACentessa Pharmaceuticals$6.88M-
LYRALyra Therapeutics$1.56M$195.00K
IOVAIovance Biotherapeutics$1.19M$58.55M
MISTMilestone Pharmaceuticals$1.00M-
LIFEaTyr Pharma$353.00K$235.00K
IKTInhibikase Therapeutics$260.50K-
XFORX4 Pharmaceuticals-$560.00K
DAWNDay One Biopharmaceuticals-$20.07M
DMACDiaMedica Therapeutics--
TERNTerns Pharmaceuticals--
ONCYOncolytics Biotech--

DMAC Revenue FAQ

What is DiaMedica Therapeutics’s yearly revenue?

DiaMedica Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. DMAC's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is DiaMedica Therapeutics’s quarterly revenue?

DiaMedica Therapeutics's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). DMAC's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is DiaMedica Therapeutics’s revenue growth rate?

DiaMedica Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.